Charles River Laboratories International (CRL) Revenue — Quarter Ended Dec 27, 2025
Revenue decreased in the quarter relative to both the prior quarter and the same period a year ago. The company's trailing twelve-month revenue reflects its ongoing operational scale.
Key takeaway
Quarter ended Dec 27, 2025 · FY2025 Q4
Revenue decreased in the quarter relative to both the prior quarter and the same period a year ago. The company's trailing twelve-month revenue reflects its ongoing operational scale.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$994.2M
Revenue reported for this quarter.
Quarter-over-quarter
-1.1%
Change from the immediately preceding quarter.
Year-over-year
-0.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 29, 2025 | $984.2M | -2.7% |
| Jun 28, 2025 | $1B | +0.6% |
| Sep 27, 2025 | $1B | -0.5% |
| Dec 27, 2025 | $994.2M | -0.8% |
Revenue performance
The reported revenue direction is a decline, driven by decreases compared to the prior quarter and the year-ago period.
Quarterly comparison
Revenue was lower than the immediately preceding quarter and also lower than the same quarter one year earlier.
What to watch
The quarterly revenue trend has shown variability, with the latest quarter marking a decline.